Yu-Juei Hsu Selected Research

Phosphates (Orthophosphate)

1/2023	High-phosphate diet causes atrial remodeling and increases atrial fibrillation vulnerability via STAT3/NF-κB signaling and oxidative stress.
10/2021	Association of Serum Phosphate with Low Handgrip Strength in Patients with Advanced Chronic Kidney Disease.
1/2021	Effects of Individualized Dietary Phosphate Control Program With a Smartphone Application in Hemodialysis Patients in Taiwan.
11/2020	High phosphate induces skeletal muscle atrophy and suppresses myogenic differentiation by increasing oxidative stress and activating Nrf2 signaling.
8/2012	Hypokalemic paralysis in a young obese female.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Juei Hsu Research Topics

Disease

13	Chronic Renal Insufficiency 01/2023 - 03/2012
9	Gitelman Syndrome 01/2017 - 02/2004
8	Inflammation (Inflammations) 03/2022 - 01/2013
7	Hypokalemia 01/2017 - 02/2004
5	Fibrosis (Cirrhosis) 01/2023 - 08/2015
5	Neoplasms (Cancer) 10/2021 - 01/2016
5	Paralysis (Palsy) 03/2015 - 09/2003
5	Alkalosis 03/2015 - 02/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2018
4	Abdominal Aortic Aneurysm 03/2022 - 01/2016
4	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 01/2018
4	Neointima 12/2020 - 01/2016
3	Cardiac Arrhythmias (Arrythmia) 12/2022 - 03/2004
3	Body Weight (Weight, Body) 08/2021 - 10/2003
3	Hypoxia (Hypoxemia) 01/2021 - 01/2016
3	Uremia 12/2020 - 02/2013
3	Proteinuria 01/2020 - 08/2014
3	Vascular Diseases (Vascular Disease) 01/2019 - 10/2003
3	Anorexia 01/2017 - 01/2013
3	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2017 - 09/2003
3	Insulin Resistance 01/2013 - 10/2003
2	Atrial Fibrillation 01/2023 - 06/2016
2	Glomerulonephritis 01/2023 - 10/2010
2	Heart Failure 12/2022 - 08/2010
2	Ischemic Stroke 12/2022 - 01/2022
2	Myocardial Infarction 12/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 12/2022 - 01/2022
2	Ureteral Obstruction 11/2022 - 01/2020
2	Aneurysm (Aneurysms) 03/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2017
2	Pneumonia (Pneumonitis) 10/2021 - 01/2017
2	Acute Lung Injury 01/2021 - 01/2017
2	Hyperphosphatemia 01/2021 - 08/2020
2	Atherosclerotic Plaque (Atheroma) 12/2020 - 01/2019
2	Hyperplasia 10/2019 - 02/2013
2	Cardiomyopathies (Cardiomyopathy) 02/2018 - 08/2015
2	Bartter Syndrome (Syndrome, Bartter) 01/2017 - 05/2005
2	Renal Insufficiency (Renal Failure) 01/2017 - 02/2013
2	Bulimia Nervosa 01/2017 - 03/2015
2	Hypertrophy 08/2015 - 02/2013
2	Acidosis 03/2015 - 01/2013
2	Hyperaldosteronism (Conn Syndrome) 03/2015 - 09/2003
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 08/2014 - 08/2007
2	Hypertension (High Blood Pressure) 03/2012 - 11/2005
2	Hypotension (Low Blood Pressure) 12/2010 - 04/2009
2	Hypercalciuria 04/2010 - 11/2006
1	Atrial Remodeling 01/2023
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2023
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2023
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 12/2022

Drug/Important Bio-Agent (IBA)

7	DiureticsIBA 01/2017 - 09/2003
5	Phosphates (Orthophosphate)IBA 01/2023 - 08/2012
5	PotassiumIBA 01/2017 - 02/2004
4	5-methoxytryptophanIBA 10/2021 - 01/2016
3	Tryptophan (L-Tryptophan)FDA Link 10/2021 - 01/2016
3	InflammasomesIBA 01/2021 - 07/2017
3	IndicanIBA 12/2020 - 08/2015
3	Apolipoproteins E (ApoE)IBA 12/2020 - 01/2019
3	CytokinesIBA 01/2020 - 01/2017
3	CreatinineIBA 09/2018 - 05/2007
3	CalciumIBA 09/2018 - 05/2007
3	SodiumIBA 01/2017 - 08/2007
3	Member 3 Solute Carrier Family 12IBA 01/2015 - 02/2004
3	Insulin (Novolin)FDA Link 01/2013 - 10/2003
3	ThiazidesIBA 08/2012 - 05/2005
2	omega-Chloroacetophenone (Mace)IBA 12/2022 - 01/2022
2	mitochondrial K(ATP) channelIBA 12/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 11/2022 - 11/2019
2	Matrix Metalloproteinases (MMPs)IBA 03/2022 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2019
2	Messenger RNA (mRNA)IBA 10/2021 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 10/2018
2	Muscarinic AntagonistsIBA 10/2021 - 01/2018
2	Aldehyde DehydrogenaseIBA 01/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 11/2020 - 11/2005
2	Vitamin D FDA LinkGeneric 01/2020 - 08/2007
2	Dosage Forms (Dosage Form)IBA 10/2018 - 01/2018
2	Urea (Carbamide)FDA LinkGeneric 09/2018 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 09/2018 - 01/2017
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2018 - 08/2015
2	Bronchodilator Agents (Bronchodilators)IBA 01/2018 - 03/2004
2	Cilostazol (Pletal)FDA LinkGeneric 01/2018 - 11/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 08/2008
2	AcidsIBA 01/2017 - 08/2007
2	Interleukin-6 (Interleukin 6)IBA 08/2016 - 10/2003
2	ElectrolytesIBA 08/2010 - 12/2009
2	LipidsIBA 09/2008 - 10/2003
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	Potassium Channels (Potassium Channel)IBA 12/2022
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	Metformin (Glucophage)FDA LinkGeneric 12/2022
1	Aquaporin 2IBA 11/2022

Therapy/Procedure

14	Therapeutics 10/2021 - 09/2002
4	Renal Dialysis (Hemodialysis) 01/2022 - 01/2017
2	Ligation 01/2021 - 01/2016
2	Nephrectomy 08/2015 - 02/2013
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2008 - 10/2003